Related content

Patient Preference for Sustained-release versus Standard Paracetamol (Acetaminophen): a Multicentre, Randomized, Open-label, Two-way Crossover Study in Subjects with Knee Osteoarthritis

By Benson M   Marangou A   Russo MA   Durocher J   Collaku A   Starkey YY  

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1321-1335

Field House Publishing

Access to resources Recommend Favorite

Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Crossover Study Comparing Patient Preference for Tamsulosin and Silodosin in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

By Watanabe T   Ozono S   Kageyama S  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 129-142

Field House Publishing

Access to resources Recommend Favorite

Development of Sustained-Release Tablets Containing Sodium Valproate: In Vitro and In Vivo Correlation

By Fujisaki Yuki   Tsukune Tadashi   Funyû Motomu   Okumura Mutsuo   Ukigaya Tadashi   Sugibayashi Kenji  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 2, 2006-03 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

Selection of 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained‐Release Prototype Formulations and Standard Acetaminophen Formulation: An Open‐Label, Randomized, Proof‐of‐Principle Pharmacokinetic Study

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 87-94

John Wiley & Sons Inc

Access to resources Recommend Favorite